Physician profile
Thomas Nebel
NPI 1053468876
$30,815.94
in general payments reported to CMS, 2019-2025
25 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $3,597 · 2021: $3,395 · 2022: $134 · 2023: $385 · 2024: $211 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $29,624.51 | 2019-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $292.06 | 2019-2023 | Stratafix, Ethicon, Vistaseal |
| Davol INC. | $140.15 | 2021-2023 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $116.04 | 2020-2025 | Gattex |
| Covidien LP | $77.82 | 2019 | |
| Abbvie INC. | $75.80 | 2023-2025 | |
| Medtronic, INC. | $69.08 | 2021-2023 | Situate, Gi Genius |
| W. L. Gore & Associates, INC. | $67.49 | 2019-2024 | Gore Enform Preperitoneal Biomaterial |
| Kerecis Limited | $61.65 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbott Laboratories | $50.30 | 2024 | Esprit |
| Teleflex LLC | $28.61 | 2025 | Manta |
| Solventum Corporation | $25.49 | 2024 | V.A.C.Instill, Activ.A.C., Prevena Restor Arthroform |
| Aroa Biosurgery Incorporated | $21.33 | 2024 | |
| Innocoll Pharmaceuticals Limited | $20.17 | 2022 | |
| Ekos Corporation | $17.77 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.56 | 2025 | |
| Olympus America INC. | $15.74 | 2023 | 4k Cable 8.5m |
| Cagent Vascular INC | $14.27 | 2022 | |
| Tela Bio, INC. | $14.18 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bard Peripheral Vascular, INC. | $12.46 | 2020 | |
| Ambu INC. | $12.30 | 2022 | |
| Braintree Laboratories, INC. | $12.09 | 2019 | |
| Cook Medical LLC | $11.07 | 2019 | |
| Penumbra, INC. | $9.67 | 2021 | |
| Polynovo North America LLC | $9.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Nebel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.